TUESDAY, June 20, 2023 (HealthDay News) — Ticks can be a problem for people who love to spend the summer outdoors, especially in certain regions of the United States. Ticks are responsible for the well-known Lyme disease and other tick-borne illnesses, said Dr. David Ingram, an infectious diseases physician andContinue Reading
THURSDAY, June 15, 2023 (HealthDay News) — Regulators want your next tattoo to be as safe as it is trendy. The U.S. Food and Drug Administration has issued a draft of new guidance aimed at helping manufacturers and distributors of tattoo inks prevent microbial contamination. “With about 30% of peopleContinue Reading
WEDNESDAY, June 14, 2023 (HealthDay News) — Hepatitis C is a viral infection of the liver no one wants to catch, so knowing how that can happen can be critical. The American Liver Foundation estimates that it affects about 2.7 million people in the United States today. To help youContinue Reading
MONDAY, June 12, 2023 (HealthDay News) — Hepatitis C is often missed in the early stages of infection, so you need to know what symptoms might spell trouble. According to the U.S. Centers for Disease Control and Prevention, hepatitis C infections, which attack the liver, are increasing at a fasterContinue Reading
MONDAY, June 12, 2023 (HealthDay News) — Hepatitis C can ruin your liver, and there’s no vaccine to prevent it, but you can take steps to lower your chances of infection. According to the U.S. Centers for Disease Control and Prevention, over 2 million U.S. adults are infected with hepatitisContinue Reading
MONDAY, June 12, 2023 (HealthDay News) — Hepatitis C is a serious viral infection that can damage your liver over time, but is there a cure for this insidious disease? Over 2 million adults in the United States are infected with hepatitis C, according to the U.S. Centers for DiseaseContinue Reading
FRIDAY, June 9, 2023 (HealthDay News) — A safe, generic diabetes pill can help people avoid long COVID, a new clinical trial shows. Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug while battling their infection, the researchers reported.Continue Reading
FRIDAY, June 9, 2023 (HealthDay News) – A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers. The monoclonal antibody shot would protect against respiratory syncytial virus (RSV) in infants born during or entering their first RSVContinue Reading
THURSDAY, June 8, 2023 (HealthDay News) — U.S. health officials are urgently trying to reach people who’ve recently had medical procedures at clinics in Matamoros, Mexico, because they may be at risk of potentially fatal fungal meningitis. Those at risk had procedures done under epidural anesthesia between Jan. 1 andContinue Reading
THURSDAY, June 8, 2023 (HealthDay News) — Hepatitis C is a serious viral infection that can scar your liver, cause your liver to fail and raise your risk for liver cancer, but there are a multitude of medications that can treat it. According to the U.S. Department of Health andContinue Reading
WEDNESDAY, June 7, 2023 (HealthDay News) — One of the signature symptoms of COVID-19 infection in the early months of the pandemic was a loss of the sense of smell. Now, new research finds that is no longer the case, thanks to the new variants that have been circulating moreContinue Reading
FRIDAY, June 2, 2023 (HealthDay News) — Genetic mutations caused this latest bird flu season to become more severe, increasing the risk it poses to humans and other mammals, a new study finds. The H5N1 avian influenza virus gained the ability to severely infect the brains of mammalian test subjectsContinue Reading
FRIDAY, June 2, 2023 (HealthDay News) — People unvaccinated for COVID-19 have significant odds of lingering illness if they get the virus, with one in six still suffering symptoms two years later, new research shows. A study from Switzerland found that 17% of that group did not return to theirContinue Reading
THURSDAY, June 1, 2023 (HealthDay News) — Older adults may have a second vaccine option for RSV following the U.S. Food and Drug Administration’s approval of a Pfizer vaccine on Wednesday. The other shot for adults 60 and up is made by GSK. It was approved May 3. Both shouldContinue Reading